Provista Diagnostics Raises $5.0M
Phoenix-based Provista Diagnostics, a developer of cancer detection and diagnostics technology, said today that it has raised $5.0M in a Series A funding round. The firm said the funding came from institutional investors, but did not announce the names of those investors. As part of the funding, Jeffrey Gilman of the Louis-Dreyfus Family Office, Anne Busquet of AMB Advisors/Golden Seeds, and John Macaskill of Groton Partners all join the company's board. Provista said it will use the funding to complete a confirmatory clinical trial and FDA 510(k) submission for its blood test for detecting breast cancer.
posted on Thursday, March 8, 2012 (Link to more information)
Related companies:
Provista Diagnostics Inc.
Related stories:
> Provista Diagnostics Raises $6.0M
> BioFire Diagnostics Lands $25M For Molecular Diagnostics Tools
> MBio Diagnostics Gets $6M
> Co-Diagnostics Snags Patent
> Exagen Diagnostics Names COO
Techrockies.com Home